Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
31 results
D1.264 - Assessment by general practitioners of a therapeutic patient education guide for allergic patients
D1.262 - Clinical significance of a basophil activation test for Japanese beekeepers naturally sensitized to honey bee venom
D1.265 - Component-Resolved Diagnosis and Clinical Profiles of Anisakis Allergy in Japan
D1.266 - Investigation of anaphylaxis in mastocytosis mouse models
D1.267 - Recurrence of perioperative anaphylaxis: analysis of a multicenter cohort
D1.268 - The endothelial glycocalyx as a therapeutic target in anaphylaxis
D1.269 - Deciphering cardiovascular profiles in sera and extracellular vesicles from anaphylactic patients. Impact in endothelial cells
D1.270 - Anaphylaxis and Adrenaline: Knowledge gaps with critical consequences
D1.271 - Bovine gelatine-induced anaphylaxis brought on by eating beef, sweets containing gelatin, and medications
D1.272 - Efficacy and Safety of Omalizumab in Treating Severe Allergic Reactions with Urticaria as the Initial Symptom
D1.273 - Anaphylactic Reaction Following Sulphur Hexafluoride Administration
D2.437 - Long-Term Analysis of the Phase 2 Open-Label Extension of Donidalorsen in Patients With Hereditary Angioedema
D2.436 - Application Study on the prevention and treatment of spleen aminopeptide oral solution on seasonal allergic rhinitis
D2.438 - Adipose-derived stem cells secretome attenuates eosinophilic inflammation in a chronic rhinosinusitis with nasal polyps mouse model
D2.439 - Low vitamin D levels in patients with allergic rhinitis and its supplementation
D2.440 - Burden of disease and patient preference in Hereditary Angioedema: findings from a mixed methods survey of carers and patients in the United Kingdom
D3.48 - The delabeling of beta-lactam allergy does not change the antibiotic prescribing profile or alerts in Primary Care. The experience of a General Hospital
D3.53 - A retrospective audit of NSAID hypersensitivity in children and young people in a tertiary paediatric allergy centre
D3.55 - Synthetic folic acid allergy
D3.47 - Implementing Penicillin Delabelling in an Inpatient setting
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download